Satomi Hashimoto

935 total citations
25 papers, 545 citations indexed

About

Satomi Hashimoto is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Satomi Hashimoto has authored 25 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Satomi Hashimoto's work include Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Immunotherapy and Immune Responses (4 papers). Satomi Hashimoto is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Immunotherapy and Immune Responses (4 papers). Satomi Hashimoto collaborates with scholars based in Japan, United States and Germany. Satomi Hashimoto's co-authors include G. Schütz, Wolfgang Schmid, Rainer Renkawitz, Ulrich Danesch, Masaaki Shiohara, Akihiro Sakurai, Koji Nakajima, Shun’ichiro Taniguchi, Hiroshi Nosé and Naoki Itano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Satomi Hashimoto

24 papers receiving 529 citations

Peers

Satomi Hashimoto
Na Du China
Yun Huang China
S. Lojo Spain
L. Kathryn Durham United States
Satomi Hashimoto
Citations per year, relative to Satomi Hashimoto Satomi Hashimoto (= 1×) peers Shaoming Zhou

Countries citing papers authored by Satomi Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Satomi Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satomi Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satomi Hashimoto more than expected).

Fields of papers citing papers by Satomi Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satomi Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satomi Hashimoto. The network helps show where Satomi Hashimoto may publish in the future.

Co-authorship network of co-authors of Satomi Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Satomi Hashimoto. A scholar is included among the top collaborators of Satomi Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satomi Hashimoto. Satomi Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Satomi, et al.. (2020). Genes encoding lipid II flippase MurJ and peptidoglycan hydrolases are required for chloroplast division in the moss Physcomitrella patens. Plant Molecular Biology. 107(4-5). 405–415. 2 indexed citations
2.
Kodaka, Yasuhiro, Seiji Futagami, Atsushi Tatsuguchi, et al.. (2017). Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification. Digestion. 96(3). 173–183. 3 indexed citations
3.
Futagami, Seiji, Tetsuro Kawagoe, Yuta Maruki, et al.. (2016). Improvement of meal‐related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan. Neurogastroenterology & Motility. 28(7). 1037–1047. 18 indexed citations
4.
Okada, Masaji, et al.. (2016). Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis. Human Vaccines & Immunotherapeutics. 13(2). 298–305. 4 indexed citations
5.
6.
Sato, Junko, Satomi Hashimoto, Takuya Doi, Naoaki Yamada, & Minoru Tsuchitani. (2014). Histological Characteristics of the Regression of Corpora Lutea in Wistar Hannover Rats: the Comparisons with Sprague-Dawley Rats. Journal of Toxicologic Pathology. 27(2). 107–113. 12 indexed citations
7.
Kita, Yoko, Satomi Hashimoto, Toshihiro Nakajima, et al.. (2013). Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy. Human Vaccines & Immunotherapeutics. 9(3). 526–533. 15 indexed citations
8.
Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2013). Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepatitis Monthly. 13(12). e14872–e14872. 12 indexed citations
9.
Okada, Masaji, Yoko Kita, Toshihiro Nakajima, et al.. (2013). The study of novel DNA vaccines against tuberculosis. Human Vaccines & Immunotherapeutics. 9(3). 515–525. 6 indexed citations
10.
Yamada, Naoaki, Satomi Hashimoto, Takuya Doi, et al.. (2013). Bacterial Pleuritis with Thickened Mesothelial Hyperplasia in a Young Beagle Dog. Journal of Toxicologic Pathology. 26(3). 313–317. 2 indexed citations
11.
Itokawa, Norio, Masanori Atsukawa, Akihito Tsubota, et al.. (2012). Lead‐in treatment with interferon‐β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha‐2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype. Journal of Gastroenterology and Hepatology. 28(3). 443–449. 2 indexed citations
12.
Atsukawa, Masanori, Akihito Tsubota, Chisa Kondo, et al.. (2012). Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b. Journal of Gastroenterology and Hepatology. 28(1). 51–56. 21 indexed citations
13.
Okada, Masaji, Yoko Kita, Noriko Kanamaru, et al.. (2011). Anti-IL-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection than Anti-TNF- Antibody in Mice. SHILAP Revista de lepidopterología. 2011. 1–9. 20 indexed citations
14.
Kosaka, Toshio, Koji Hosokawa, Nobuaki Shime, et al.. (2011). Effects of renal function on the pharmacokinetics and pharmacodynamics of prophylactic cefazolin in cardiothoracic surgery. European Journal of Clinical Microbiology & Infectious Diseases. 31(2). 193–199. 13 indexed citations
15.
Doi, Takuya, Kazuaki W. TAKAHASHI, Satomi Hashimoto, et al.. (2010). Malignant Mesothelioma in the Thoracic Cavity of a Crj:CD(SD) Rat Characterized by Round Hyalinous Stroma. Journal of Toxicologic Pathology. 23(2). 103–106. 4 indexed citations
16.
Nakajima, Koji, Michiko Takeoka, Masayuki Mori, et al.. (2010). Exercise Effects on Methylation ofASCGene. International Journal of Sports Medicine. 31(9). 671–675. 116 indexed citations
17.
Okada, Masaji, Yoko Kita, Noriko Kanamaru, et al.. (2008). Novel Therapeutic Vaccination(granulysin DNA, adenoviral vector/IL‐6 related genes) against Tuberculosis. The FASEB Journal. 22(S2). 491–491. 2 indexed citations
19.
Aoyama, H, Satomi Hashimoto, Hiroki Shirato, et al.. (1998). The suppression of metastases and the change in host immune response after low dose total body irradiation to tumor-bearing rats. International Journal of Radiation Oncology*Biology*Physics. 42(1). 240–240. 4 indexed citations
20.
Hashimoto, Satomi, Wolfgang Schmid, & G. Schütz. (1984). Transcriptional activation of the rat liver tyrosine aminotransferase gene by cAMP.. Proceedings of the National Academy of Sciences. 81(21). 6637–6641. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026